SGMO

Sangamo Therapeutics, Inc.

A biotechnology company that makes genomic medicines using zinc finger proteins—natural human proteins engineered to bind specific DNA sequences, enabling gene therapy and genome editing for serious diseases. Founded in 1995 by Edward Lanphier, its name was inspired by the Sangamon River in Illinois, borrowed from the earlier Sangamo Electric Company that Lanphier's relatives helped found a century earlier.

Recent Activity

Show $

2016Q3

1 sell

First Eagle Investment ManagementEXIT

-60.0K shares

First Eagle Investment ManagementEXIT

-60.0K shares

2016Q2

1 sell

First Eagle Investment ManagementTRIM

-319.7K shares(-84.2%)

First Eagle Investment ManagementTRIM

-319.7K shares(-84.2%)

2016Q1

1 buy

First Eagle Investment ManagementADD

+179.7K shares(+89.9%)

First Eagle Investment ManagementADD

+179.7K shares(+89.9%)

Loading more activity...